The effects of sodium bicarbonate infusion on cerebrovascular function in newborn pigs.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34862458.
- Also identified by DOI 10.1038/s41390-021-01876-x and PMC identifier 9163205.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sodium bicarbonate (NaHCO<sub>3</sub>) is no longer recommended by the Neonatal Resuscitation Program (NRP), but is still being used by some neonatologists. The effects of NaHCO<sub>3</sub> on cerebral hemodynamics are unclear. Therefore, we investigated the effects of NaHCO<sub>3</sub> on cerebral blood flow (CBF) and cerebrovascular function using a newborn piglet model. Newborn pigs were anesthetized, intubated, and ventilated. Cranial windows were implanted to evaluate changes in pial arteriolar diameters (PADs) as a surrogate for CBF during a 4-h intravenous infusion of 3% NaHCO<sub>3</sub>. Cerebrovascular reactivity to vasodilators and vasoconstrictors was investigated during vehicle control and during NaHCO<sub>3</sub> infusion. NaHCO<sub>3</sub> infusion caused significant and progressive pial arteriolar vasoconstrictions. During NaHCO<sub>3</sub> infusion, cerebrovascular reactivity was preserved. Adding vasodilators decreased cerebral vasoconstriction, while adding vasoconstrictors exaggerated cerebral vasoconstriction. Intravenous infusion of NaHCO<sub>3</sub> over 4 h caused progressive vasoconstriction of pial arterioles. Cerebrovascular function evaluated by the responses of pial arterioles to physiologically relevant vasoconstrictors and vasodilators was preserved during NaHCO<sub>3</sub> infusion. A notable additional reduction of PADs was observed during NaHCO<sub>3</sub> infusion in the presence of vasoconstrictors. Extrapolating our findings to human neonates should alarm the clinicians that using NaHCO<sub>3</sub> in neonates may cause cerebral hypoperfusion. Cerebral vasoconstriction occurs during slow infusion of 3% diluted NaHCO<sub>3</sub>. Cerebral vasoconstriction is exaggerated when another vasoconstrictor is added during NaHCO<sub>3</sub> infusion. Cerebrovascular function is preserved during NaHCO<sub>3</sub> infusion. Clinicians should be aware of the risk of cerebral hypoperfusion with NaHCO<sub>3</sub> infusion in vulnerable neonates.
Medical subject headings
- Resuscitation
- Sodium Bicarbonate